Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/2012
08/02/2012US20120195933 Pharmaceutical compositions comprising tasocitinib
08/02/2012US20120195932 Geodate delivery vehicles
08/02/2012US20120195836 Foamable Iodine Compositions
08/02/2012US20120195826 Injectable biomaterial
08/02/2012US20120192861 Aerosol pirfenidone and pyridone analog compounds and uses thereof
08/02/2012CA2826098A1 Detachable drug delivery device
08/02/2012CA2825877A1 Oral dosage forms for modified release comprising tasocitinib
08/02/2012CA2825858A1 Phosphorus-containing group-substituted quinoline, its preparation process, medical composition containing the compound and application
08/02/2012CA2825845A1 Process for preparation of a herbal extract
08/02/2012CA2825808A1 Method, composition and package for bowel cleansing
08/02/2012CA2825512A1 Radiopaque embolic particles
08/02/2012CA2825473A1 Protection of microbial cells from acidic degradation
08/02/2012CA2825417A1 Liposome and personal care composition comprising thereof
08/02/2012CA2825396A1 Androgen composition for treating an opthalmic condition
08/02/2012CA2825256A1 Drug delivery systems
08/02/2012CA2825252A1 Compositions and methods for cell transplantation
08/02/2012CA2825016A1 Nanoparticles for dermal and systemic delivery of drugs
08/02/2012CA2824982A1 Medical device containing a cake composition comprising aripiprazole as an active ingredient, and a cake composition comprising aripiprazole as an active ingredient
08/02/2012CA2824941A1 Testosterone formulations
08/02/2012CA2824766A1 Highly penetrating compositions and methods for treating pathogen-induced disordered tissues
08/01/2012EP2481747A1 Methods of treating cutaneous flushing using selective alpha-2-adrenergic receptor agonists
08/01/2012EP2481443A1 Patch
08/01/2012EP2481416A1 Eye drops
08/01/2012EP2481411A1 Oral dosage forms for modified release comprising the JAK3 inhibitor tasocitinib
08/01/2012EP2481409A2 Nanoparticle comprising rapamycin and albumin as anticancer agent
08/01/2012EP2481405A1 Nanoparticles of paclitaxel and albumin in combination with bevacizumab against cancer
08/01/2012EP2481403A1 Pharmaceutical combination of otilonium and trimebutine
08/01/2012EP2481402A2 Nanoparticle comprising rapamycin and albumin as anticancer agent
08/01/2012EP2481401A1 Lipophilic microparticles containing a protein drug or antigen and formulation comprising same
08/01/2012EP2481400A1 Oral controlled release compositions comprising vitamin D compound and waxy carrier
08/01/2012EP2481399A1 Sustained drug delivery system
08/01/2012EP2481398A1 Slow-release cilostazol tablet having an improved elution rate and minimal side effects
08/01/2012EP2481397A1 Pharmaceutical compositions comprising tasocitinib
08/01/2012EP2481396A2 Oxaliplatin nanoparticles and method for preparing same
08/01/2012EP2481395A1 Sachet, effervescent tablet and dry syrup of otilonium
08/01/2012EP2480287A2 Dry powder combination of tiotropium
08/01/2012EP2480256A2 Chemically amplified response strategies for medical sciences
08/01/2012EP2480249A1 Use of plasmin for the treatment of filtration failure after trabeculectomy
08/01/2012EP2480246A2 Composition and method for treatment of diabetes
08/01/2012EP2480236A1 Compositions and methods for treating bacterial infections using ceftaroline
08/01/2012EP2480234A2 Sustained release composition of ranolazine
08/01/2012EP2480226A2 Composition comprising s-allyl-l-cysteine as active ingredient for preventing or treating gastrointestinal disorders
08/01/2012EP2480225A2 Dermal formulations of dp2 receptor antagonists
08/01/2012EP2480222A1 Biodegradable foams with improved dimensional stability
08/01/2012EP2480221A2 Process for the manufacture of nicotine-comprising chewing gum and nicotine-comprising chewing gum manufactured according to said process
08/01/2012EP2480220A2 Treatment and prevention of hiv infection
08/01/2012EP2480219A1 Lipid nanocapsules, method for preparing same, and use thereof as a drug
08/01/2012EP2480218A1 Acid resistant capsules
08/01/2012EP2480217A1 Manufacture of chewing gum product with radiofrequency
08/01/2012EP2480216A1 Manufacture of tablet in a die utilizing radiofrequency energy and meltable binder
08/01/2012EP2480215A1 Manufacture of lozenge product with radiofrequency
08/01/2012EP2480214A1 Orally transformable tablets
08/01/2012EP2480213A1 Manufacture of tablet having immediate release region and sustained release region
08/01/2012EP2480212A1 Oral pharmaceutical composition comprising diclofenac
08/01/2012EP2480211A1 Galenic form suitable for absorbing, in a specific manner, the undesirable molecules in the digestive tract
08/01/2012EP2480210A2 Active agent loaded uniform, rigid, spherical, nanoporous calcium phosphate particles and methods of making and using the same
08/01/2012EP2480209A1 Methods for the preparation of liposomes comprising docetaxel
08/01/2012EP2480208A1 Methods for the preparation of liposomes
08/01/2012EP2480207A2 Micelle encapsulation of therapeutic agents
08/01/2012EP2480206A1 Dicyclanil-based aqueous suspension and non-aqueous solution pour-on and spray on formulations for the prevention and treatment of insect infestation in animal
08/01/2012EP2480205A1 Injectable aqueous ophthalmic composition and method of use therefor
08/01/2012EP2480204A2 Topical formulation for diabetic foot ulcers
08/01/2012EP2480203A2 Dry powder formulation of tiotropium carried in blister strip
08/01/2012EP2480202A2 Carrying of a combination containing tiotropium in a blister strip
08/01/2012EP2480201A2 Manufacture of tablet in a die utilizing powder blend containing water-containing material
08/01/2012EP2480200A2 Implant devices having varying bioactive agent loading configurations
08/01/2012EP2480199A1 Implant devices for modulating bioactive agent release profiles
08/01/2012EP2480198A2 Stabilized liquid and lyophilized adamts13 formulations
08/01/2012EP2480197A2 Formulations comprising triptan compounds
08/01/2012EP2252264B1 Injectable biocompatible composition
08/01/2012EP2219625B1 Drug-containing nanoparticles comprising pioglitazone
08/01/2012EP2211843B1 Pharmaceutical moire pill
08/01/2012EP2206519B1 Medicinal preparation for oral administration
08/01/2012EP2127646B1 Agent for relief or prevention of xerostomia
08/01/2012EP2034970B1 Sustained release pharmaceutical formulation comprising phenylephrine
08/01/2012EP1885337B1 Medicament, particularly an anti-cancer medicament, for treatment using immunotherapy, particularly autologous
08/01/2012EP1871423B1 Nanoparticle/active ingredient conjugate
08/01/2012EP1871345B1 Nanoparticulate erlotinib formulations
08/01/2012EP1853310B1 Anti a beta antibody formulation
08/01/2012EP1830816B1 Solid dosage form comprising proton pump inhibitor and suspension made thereof
08/01/2012EP1806152B1 Drug for external use and adhesive patch
08/01/2012EP1765894B9 Novel temperature and ph sensitive copolymers
08/01/2012EP1679085B1 Pressure-sensitive adhesive sheet for application to skin
08/01/2012EP1633395B1 Functionally reconstituted viral membranes containing adjuvant
08/01/2012EP1560585B1 Dosage form that is safeguarded from abuse
08/01/2012EP1545634B1 Method of preparing dry powder inhalation compositions
08/01/2012EP1432407B2 Lisinopril compositions having large-particle dcpd
08/01/2012EP1369133B1 Gene carriers comprising a beta-1,3-glucan and process for producing the same
08/01/2012EP1253910B1 Combined diffusion/osmotic pumping drug delivery system
08/01/2012EP1181057B1 Noninvasive genetic immunization, expression products therefrom, and uses thereof
08/01/2012EP0961612B2 Protein stabilized pharmacologically active agents and their use
08/01/2012CN202355606U Product with deodorant device
08/01/2012CN202355497U Cold compressing patch
08/01/2012CN1874764B Sustained-release microgranules containing ginkgo extract and the process for manufacturing these
08/01/2012CN1292714B Aerosolized active agent delivery
08/01/2012CN1224610B Ibuprofen compositions
08/01/2012CN102625715A Seamless alginate capsules
08/01/2012CN102625698A Nicotine dissolving film with or without menthol
08/01/2012CN102625697A Delivery of therapeutic agents using oligonucleotide-modified nanoparticles as carriers
08/01/2012CN102625696A Improved lipid formulation
1 ... 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 ... 2991